Enabling confident differential diagnostics in dementia
cNeuro is Combinostics’ cloud platform for quantitative assessment of brain images and for providing clinical decision support in neurological disorders.
Combinostics offers two modules in the cNeuro product family, cMRI and cDSI.
Quantify volumes of 133 brain regions, vascular burden, medial temporal lobe atrophy (MTA) score, global cortical atrophy (GCA) scale and Fazekas scale.
Compare measures to reference data.
Review results interactively in a web viewer using a standard web browser and obtain a report.
Compare neuropsychology, MRI, CSF and genetics measured from your patient to data of previously diagnosed cases.
Quantify the patient’s similarity relative to etiology (AD, FTLD, VaD and cognitive normal) and progression (stable and progressive MCI).
Visualize data in an intuitive way with our patented disease state fingerprint (DSI) technology.
Combinostics selected for the MassChallenge HealthTech’s 2019 Cohort of Top Digital Health Companies
Combinostics today announced that the company has been selected for the MassChallenge HealthTech 2019 program in Boston. MassChallenge is a global network of zero-equity startup accelerators. Combinostics was selected for the Boston program by a pool of institutions,...read more
Combinostics will have a booth at RSNA 2018 from November 25 to 30. Please come and visit us! We can be found within the Machine Learning Showcase exhibition: North – Hall kiosk 7367M.read more
Combinostics will be attending the AAIC conference in Chicago July 22-26. We will showcase our cNeuro® cMRI application for quantitative analysis of MRI scans, and our cNeuro® cDSI application for clinical decision support in differential diagnostics in dementia....read more